Ceredex Value Advisors’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,038,700
Closed -$55.6M 171
2022
Q4
$55.6M Sell
2,038,700
-224,250
-10% -$5.98M 0.86% 47
2022
Q3
$53.9M Sell
2,262,950
-505,550
-18% -$13.9M 0.88% 49
2022
Q2
$77.4M Sell
2,768,500
-1,851,845
-40% -$53.9M 1.16% 24
2022
Q1
$135M Buy
4,620,345
+355,407
+8% +$11.1M 1.62% 15
2021
Q4
$149M Buy
4,264,938
+830,321
+24% +$29.5M 1.61% 20
2021
Q3
$113M Buy
3,434,617
+3,083,776
+879% +$99.6M 1.28% 24
2021
Q2
$11.6M Buy
350,841
+85,800
+32% +$2.98M 0.13% 120
2021
Q1
$9.45M Sell
265,041
-15,000
-5% -$533K 0.11% 113
2020
Q4
$9.5M Buy
280,041
+4,341
+2% +$134K 0.12% 106
2020
Q3
$7.1M Sell
275,700
-1,600
-0.6% -$42.5K 0.1% 105
2020
Q2
$7.15M Buy
+277,300
New +$6.95M 0.11% 110

Other funds holding GNTX

Ceredex Value Advisors's GNTX Position: Q1 2023 in Review

Ceredex Value Advisors sold out of Gentex (GNTX) in Q1 2023, closing a stake of 2,038,700 shares — an estimated $55.6M sold.

Ceredex Value Advisors first reported a position in GNTX in Q2 2020 and held it in 11 quarters. The position peaked at $149M in Q4 2021. 481 funds tracked by Wall St. Rank hold GNTX as of Q1 2023.

  • Ceredex Value Advisors reported no remaining Gentex position as of Q1 2023 after selling out during the quarter.
  • Ceredex Value Advisors sold 2,038,700 Gentex shares in Q1 2023, an estimated $55.6M.
  • Ceredex Value Advisors first reported a position in Gentex in Q2 2020 and held it in 11 quarters.
  • Ceredex Value Advisors's Gentex position peaked at $149M in Q4 2021.
  • 481 funds tracked by Wall St. Rank held Gentex as of Q1 2023.

Based on Ceredex Value Advisors's 13F filing for Q1 2023, filed 26 Apr 2023.